Spire Healthcare Group plc
SPI.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | £1,511 | £1,359 | £1,199 | £1,106 |
| % Growth | 11.2% | 13.4% | 8.3% | – |
| Cost of Goods Sold | £828 | £838 | £758 | £712 |
| Gross Profit | £684 | £521 | £441 | £394 |
| % Margin | 45.2% | 38.3% | 36.8% | 35.6% |
| R&D Expenses | £0 | £0 | £0 | £0 |
| G&A Expenses | £0 | £0 | £0 | £0 |
| SG&A Expenses | £0 | £394 | £336 | £313 |
| Sales & Mktg Exp. | £0 | £0 | £0 | £0 |
| Other Operating Expenses | £546 | £0 | £0 | £0 |
| Operating Expenses | £546 | £394 | £336 | £313 |
| Operating Income | £138 | £127 | £104 | £81 |
| % Margin | 9.1% | 9.3% | 8.7% | 7.3% |
| Other Income/Exp. Net | -£99 | -£92 | -£100 | -£83 |
| Pre-Tax Income | £38 | £35 | £4 | -£2 |
| Tax Expense | £12 | £7 | -£4 | £7 |
| Net Income | £25 | £27 | £9 | -£10 |
| % Margin | 1.7% | 2% | 0.7% | -0.9% |
| EPS | 0.063 | 0.068 | 0.021 | -0.024 |
| % Growth | -6.8% | 215.9% | 188.4% | – |
| EPS Diluted | 0.062 | 0.066 | 0.021 | -0.024 |
| Weighted Avg Shares Out | 403 | 404 | 403 | 401 |
| Weighted Avg Shares Out Dil | 411 | 413 | 412 | 401 |
| Supplemental Information | – | – | – | – |
| Interest Income | £1 | £1 | £0 | £87 |
| Interest Expense | £98 | £93 | £92 | £87 |
| Depreciation & Amortization | £112 | £104 | £98 | £97 |
| EBITDA | £250 | £231 | £193 | £182 |
| % Margin | 16.6% | 17% | 16.1% | 16.5% |